Pathophysiological and Molecular Insights into Heart Failure: From Diagnosis to Therapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 1499
Special Issue Editor
Interests: cardiology; heart failure; pharmacology; therapy; genetic; coronary microvascular dysfunction
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Heart failure (HF) is a complex and multifaceted syndrome that is associated with a progressive and multisystemic involvement leading, in the advanced stages, to multiorgan dysfunction. It is characterized by high mortality and morbidity rates. Several pathways are involved in HF pathophysiology, representing pivotal therapeutic targets. However, new molecules have been identified as potential diagnostic, prognostic and therapeutic biomarkers. In this case, microRNAs have been identified as promising tools, while other myocardial markers, such as Brain Natriuretic Peptides, High Sensitivity Cardiac Troponins have shown prognostic power to help cardiologists for the management of HF patients. In particular, they may be useful to guide the up-titration of pharmacological therapy and to identify a subclinical HF worsening requiring therapy modification or more advanced strategies of treatment.
Besides the pharmacological treatment, several trials have shown the benefit of implantable electrical therapeutical technology, such as cardiac resynchronization therapy and cardiac contractility modulation, in order to reduce hospitalization due to HF and CV mortality. They also demonstrated to be effective in improving the life quality of HF patients.
To better highlight the recent advances in HF, this Special Issue will focus on new findings regarding pathophysiology, molecular and genetic aspects of HF in terms of diagnostic, prognostic and therapeutic tools. Original articles, reviews of current literature and original perspectives on this topic will be taken into account.
Dr. Paolo Severino
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heart failure
- pathophysiology
- diagnosis
- pharmacological therapy
- device therapy
- microRNAs
- myocardial biomarkers
- molecular pathways
